Table 2. Clinical and virological features of patients with detectable virus in the bloodstream.
| Patient | Age/sex | History of consumption of shellfish | Underlying liver disease | Bilirubin (μmol/L) at admission | ALT (U/L) at admission | Viral load (copies/mL of serum); time since symptom onset | Genotype |
|---|---|---|---|---|---|---|---|
| 1 | 66/M | No | NAFLD | 59.3 | 3645 | 8.29 × 106; 3 days | 4b |
| 2 | 50/M | No | NAFLD | 115.4 | 2991 | 1.31 × 104; ~2 weeks | NA |
| 3 | 55/M | Yes | AFLD | 68.6 | 785 | 1.42 × 104; 15 days | NA |
| 4 | 40/F | No | None | 11.7 | 707 | 1.79 × 104; 12 days | 4b |
| 5 | 43/F | No | Hepatitis B carrier | 16.5 | 2771 | 1.37 × 105; 11 days | 4b |
| 6 | 36/M | No | NAFLD | 8.5 | 616 | 4.23 × 104; NA | NA |
| 7 | 44/M | No | None | 30.5 | 2189 | 4.99 × 106; 10 days | 4b |
| 8 | 39/M | Yes | None | 35.9 | 1668 | 1.43 × 104; 7 days | 4b |
Abbreviations: alcoholic fatty liver disease (AFLD); alanine aminotransferase (ALT); female (F); male (M); not available (NA); NAFLD, non-alcoholic fatty liver disease (NAFLD).